SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spero Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Spero Therapeutics, Inc. ("Spero" or the "Company") (NASDAQ: SPRO)...

Related Keywords

New York ,United States ,Paris ,France General ,France ,Chicago ,Illinois ,Tel Aviv ,Israel ,Los Angeles ,Abrahaml Pomerantz ,Roberts Willoughby ,Prnewswire Pomerantz ,United States District Court ,Securities Exchange ,Drug Administration ,Spero Therapeutics Inc ,Spero Therapeutics ,Eastern District ,Securities Exchange Act ,Class Period ,Lead Plaintiff ,Tebipenem Pivoxil Hydrobromide ,New Drug Application ,Complicated Urinary Tract Infections ,Late Cycle Meeting ,Pomerantz Llp ,